148 related articles for article (PubMed ID: 2474165)
1. Effect of a new cholecystokinin receptor antagonist CR 1392 on caerulein-induced acute pancreatitis in rats.
Otsuki M; Tani S; Okabayshi Y; Nakamura T; Fujii M; Fujisawa T; Baba S; Itoh H
Pancreas; 1989; 4(2):237-43. PubMed ID: 2474165
[TBL] [Abstract][Full Text] [Related]
2. Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models.
Tani S; Okabayashi Y; Nakamura T; Fujii M; Itoh H; Otsuki M
Pancreas; 1990 May; 5(3):284-90. PubMed ID: 2343042
[TBL] [Abstract][Full Text] [Related]
3. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
[TBL] [Abstract][Full Text] [Related]
4. Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin.
Niederau C; Ferrell LD; Grendell JH
Gastroenterology; 1985 May; 88(5 Pt 1):1192-204. PubMed ID: 2984080
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
Varga G; Papp M; Scarpignato C
Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419
[TBL] [Abstract][Full Text] [Related]
6. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
[TBL] [Abstract][Full Text] [Related]
7. Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat.
Sperti C; Militello C; Rovati L; Behboo R; Khajeturian E; Perasole A; Alaggio R; Pedrazzoli S
J Surg Oncol; 1994 Sep; 57(1):11-6. PubMed ID: 8065144
[TBL] [Abstract][Full Text] [Related]
8. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
Nakano S; Kihara Y; Otsuki M
Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and mice.
Makovec F; Bani M; Cereda R; Chistè R; Revel L; Rovati LC; Setnikar I; Rovati LA
Peptides; 1986; 7(6):1159-64. PubMed ID: 3104890
[TBL] [Abstract][Full Text] [Related]
10. Experimental acute pancreatitis induced by excessive doses of caerulein in rats; protective and therapeutic effects of trypsin inhibitor urinastatin and CCK receptor antagonist CR1392.
Tani S
Kobe J Med Sci; 1988 Apr; 34(2):93-112. PubMed ID: 3216603
[No Abstract] [Full Text] [Related]
11. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
Scarpignato C; Varga G; Dobronyi I; Papp M
Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
[TBL] [Abstract][Full Text] [Related]
12. Effect of lorglumide (CR-1409) on pancreatic secretory and trophic response to caerulein in newborn rats.
Papp M; Varga G; Folly G
Acta Physiol Hung; 1991; 78(1):61-7. PubMed ID: 1722380
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic and protective effect of subcutaneous injections of L-364,718 on caerulein-induced acute pancreatitis.
Garcia-Montero AC; Manso MA; Rodriguez AI; De Dios I
Pancreas; 1994 May; 9(3):309-15. PubMed ID: 7517544
[TBL] [Abstract][Full Text] [Related]
14. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis.
Nakano S; Tachibana I; Otsuki M
Pancreas; 1995 Apr; 10(3):287-94. PubMed ID: 7542770
[TBL] [Abstract][Full Text] [Related]
15. The effect of the CCK receptor antagonist CR 1409 on bile reflux pancreatitis in the opossum.
Larsen F; Schlarman D; Andrus CC; Kaminski DL
Pancreas; 1991 May; 6(3):291-7. PubMed ID: 1713673
[TBL] [Abstract][Full Text] [Related]
16. Different effects of dexamethasone and the nitric oxide synthase inhibitor L-NAME on caerulein-induced rat acute pancreatitis, depending on the severity.
Sugiyama Y; Kato S; Abe M; Mitsufuji S; Takeuchi K
Inflammopharmacology; 2005; 13(1-3):291-301. PubMed ID: 16259748
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of CR-1409 on amylase secretion and intracellular Ca2+ mobilization in rat pancreatic acini in vitro.
Shinozaki H; Funakoshi A; Wakasugi H; Abe M
Jpn J Physiol; 1989; 39(4):585-93. PubMed ID: 2481056
[TBL] [Abstract][Full Text] [Related]
18. Histologic and biochemical alterations in experimental acute pancreatitis induced by supramaximal caerulein stimulation.
Tani S; Otsuki M; Itoh H; Fujii M; Nakamura T; Oka T; Baba S
Int J Pancreatol; 1987; 2(5-6):337-48. PubMed ID: 2447208
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
[TBL] [Abstract][Full Text] [Related]
20. Effects of the cholecystokinin receptor antagonist L-364,718 on experimental pancreatitis in mice.
Silverman M; Ilardi C; Bank S; Kranz V; Lendvai S
Gastroenterology; 1989 Jan; 96(1):186-92. PubMed ID: 2462522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
